ART26.12

1 1

Selleck Chemicals

E4780-5MG

€193,00 EUR
€193,00 EUR
Sale Sold out
Taxes included. Shipping calculated at checkout.
Size
View full details

ART26.12 is an inhibitor of Cannabinoid Receptors used in studies of GPCR Signaling. It is especially relevant when investigators need a named chemical input and interpretable readouts connected to receptor-driven second-messenger signaling and desensitization dynamics in metabolism and neuroscience models.

By inhibiting Cannabinoid Receptors, ART26.12 can be used to examine receptor-driven second-messenger signaling and desensitization dynamics. The gpcr annotation adds relevance to GPCR pharmacology, ligand-binding, and signaling assays, together with downstream-response mapping in the same experimental setting. In metabolism and neuroscience models, these readouts can be combined with viability, reporter, localization, biochemical conversion, or morphology endpoints to refine experimental interpretation.

Research Applications

  • Target-focused assays involving Cannabinoid Receptors
  • Pathway perturbation studies connected to GPCR Signaling
  • Concentration-response inhibition and target-dependence studies
  • GPCR pharmacology, ligand-binding, and signaling assays

Overall, ART26.12 is appropriate when a defined chemical perturbant is needed to connect Cannabinoid Receptors with measurable biochemical, transcriptional, electrophysiological, imaging, or phenotypic readouts in metabolism and neuroscience models. This profile is suited to mechanistic follow-up, comparative profiling, and assay optimization under defined exposure conditions.

Targets:
Cannabinoid Receptors
Target Class:
GPCR
Pathways:
GPCR Signaling
Research Area:
Metabolism • Neuroscience
CAS No.:
2766800-24-0
Molecular Weight:
472.53
Formula:
C₂₉H₂₈O₆
Storage Temperature:
-20°C

For Research Use Only. Not intended for diagnostic or therapeutic use.
Products may be subject to intellectual property rights.

The purchase of this product does not grant any license for commercial use, manufacturing, or clinical applications. The user is responsible for ensuring compliance with applicable laws and third-party rights.